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Identity 
Other names: BUBR1: Bub1A; MAD3L 




The gene spans 60 kb and is composed of 23 exons. 
Protein 
Note 
Protein name: BUBR1 
Description 





Cytoplasmic in interphase cells. Bound to BUB3 or 
CENPE, it can be localized to nuclear kinetochores. 
Function 
A central component of the mitotic spindle checkpoint 
that directly inhibits the anaphase-promoting 
complex/cyclosome until sister chromatids are 
correctly attached to the spindle, thus ensuring proper 
chromosome segregation during cell division. Also 
binds the motor protein CENPE, an interaction required 
for regulation of kinetochore-microtubule interactions 
and checkpoint signalling. 
Homology 
BUBR1 is the mammalian homolog of yeast Mad3, a 
significant difference being that BUBR1 possesses a 





Figure 1: Schematic representation of BUB1B demonstrating the relative exon sizes (introns are not drawn to scale) 










Figure 2 : Schematic representation of BUBR1 showing position of mutations, with truncating mutations depicted above the protein and 




See figure 2 above. 
Germinal 
Biallelic germline mutations found in five Mosaic 
Variegated Aneuploidy (MVA) cases. Each family 
carries one missense mutation and one mutation that 
results in premature protein truncation or an absent 
transcript. 
Somatic 
Deletion of T at codon 1023 predicted to remove part 
of the kinase domain. 
Implicated in 
Mosaic variegated aneuploidy (MVA) 
Note 
Is a rare recessive condition characterised by mosaic 
aneuploidies, predominantly trisomies and 
monosomies, involving multiple different 
chromosomes and tissues. Affected individuals 
typically present with severe intrauterine growth 
retardation and microcephaly. Eye anomalies, mild 
dysmorphism, variable developmental delay and a 
broad spectrum of additional congenital abnormalities 
and medical conditions may also occur. 
Prognosis 
There is early mortality in a significant proportion of 
cases due to failure to thrive and/or complications of 
congenital abnormalities, epilepsy, infections or 
malignancy. 
Cytogenetics 
The proportion of aneuploid cells varies but is  
usually >25% and is substantially greater than in 
normal individuals. 
Oncogenesis 
The risk of malignancy in MVA is high, with 
rhabdomyosarcoma, Wilms tumour and leukaemia 
reported in several cases. Two of the five cases with 
BUB1B mutations developed an embryonal 
rhabdomyosarcoma. 
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